Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial.

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial. Hypertension. 2020 07; 76(1):144-149.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Albuminuria
Contraindications, Drug
Creatinine
Double-Blind Method
Drug Resistance
Female
Glomerular Filtration Rate
Humans
Hypertension, Renal
Male
Middle Aged
Mineralocorticoid Receptor Antagonists
Piperidines
Pyrazoles
Quinolines
Renal Insufficiency, Chronic
Spironolactone
Young Adult

authors with profiles

George Bakris